@techcrunch.com 4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@techcrunch.com 5 years ago
China is funding the future of American biotech
@techcrunch.com 6 years ago
Tradewind Bioscience attacks the physiology of tumors to treat cancer
@techcrunch.com 6 years ago
Health startup Buoy raises $6.7 million to invest in recruitment and research
@techcrunch.com 7 years ago
DrChrono raises $12 million in Series A to take on older EHR platforms like Athena Health
@techcrunch.com 8 years ago
Marijuana deliverer Meadow rolls up $2.1M for dispensary sales software
@techcrunch.com 8 years ago
TrialMatch Aims To Ease The Pain Of Clinical Trials Recruitment